These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1316862)

  • 21. Characterization of the plasmid mediated beta-lactamase BIL-1.
    Payne DJ; Woodford N; Amyes SG
    J Antimicrob Chemother; 1992 Aug; 30(2):119-27. PubMed ID: 1399921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
    Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y
    Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
    Reading C; Farmer T; Cole M
    J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five novel plasmid-determined beta-lactamases.
    Medeiros AA; Cohenford M; Jacoby GA
    Antimicrob Agents Chemother; 1985 May; 27(5):715-9. PubMed ID: 3925874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers.
    Gulay Z; Bicmen M; Amyes SG; Yulug N
    J Chemother; 2000 Jun; 12(3):208-15. PubMed ID: 10877515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime.
    Imtiaz U; Manavathu EK; Mobashery S; Lerner SA
    Antimicrob Agents Chemother; 1994 May; 38(5):1134-9. PubMed ID: 8067751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli.
    Weber DA; Sanders CC; Bakken JS; Quinn JP
    J Infect Dis; 1990 Aug; 162(2):460-5. PubMed ID: 2197339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
    Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France.
    Henquell C; Sirot D; Chanal C; De Champs C; Chatron P; Lafeuille B; Texier P; Sirot J; Cluzel R
    J Antimicrob Chemother; 1994 Nov; 34(5):707-14. PubMed ID: 7706166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.
    Caniça MM; Barthélémy M; Gilly L; Labia R; Krishnamoorthy R; Paul G
    Antimicrob Agents Chemother; 1997 Feb; 41(2):374-8. PubMed ID: 9021194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola].
    Farzaneh S; Péduzzi J; Demachy MC; Barthélémy M; Labia R
    Pathol Biol (Paris); 1995 Apr; 43(4):315-9. PubMed ID: 7567122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.
    Caniça MM; Lu CY; Krishnamoorthy R; Paul GC
    J Mol Evol; 1997 Jan; 44(1):57-65. PubMed ID: 9010136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the beta-lactamase resistance to clavulanic acid.
    Saves I; Burlet-Schiltz O; Swarén P; Lefèvre F; Masson JM; Promé JC; Samama JP
    J Biol Chem; 1995 Aug; 270(31):18240-5. PubMed ID: 7629142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAR-2: identification of a novel plasmid-encoded beta-lactamase from India.
    Nandivada LS; Amyes SG
    FEMS Microbiol Lett; 1989 Jan; 48(2):219-21. PubMed ID: 2656382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
    Aktaş Z; Gönüllü N; Schneider I; Bal C; Bauernfeind A
    Mikrobiyol Bul; 2005 Oct; 39(4):421-9. PubMed ID: 16544543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli.
    Henquell C; Chanal C; Sirot D; Labia R; Sirot J
    Antimicrob Agents Chemother; 1995 Feb; 39(2):427-30. PubMed ID: 7726509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.